Nanosized carriers based on amphiphilic poly-N-vinyl-2-pyrrolidone for intranuclear drug delivery

What is it about?

New therapies require drug delivery systems capable of delivering drugs into cell nuclei. We found that by tailoring the size distribution of polymeric nanocarriers we can give or take away from them the ability to penetrate into cell nuclei, offering a promising new approach in cancer therapies.

Featured Image